ClinicalTrials.Veeva

Menu

Identification of Spine Structures by Using BIP-Needles

I

Injeq

Status

Completed

Conditions

Spinal Puncture

Treatments

Device: Injeq Bioimpedance Probe (BIP) Needle

Study type

Interventional

Funder types

Industry

Identifiers

NCT02602912
INJ-SPINE-01

Details and patient eligibility

About

The main purpose of the study is to assess the feasibility and clinical performance of impedance based tissue identification in various spine structures.

Enrollment

69 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Voluntary adult patients going through medical operation involving spinal puncture, spinal fluid sampling or intrathecal drug injection.

Exclusion criteria

  • Participation to other clinical study
  • Exclusion criteria are the same as generally for spinal anaesthesia and lumbar punctures. Exclusion criteria includes infection on skin area, systemic anticoagulation, sepsis, anatomical unsuitability and refusal
  • In addition for not giving (or not capable to give) the consent personally for any reason is an absolute exclusion criterion. In practice this means that study is for adult patients only.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

69 participants in 1 patient group

Injeq Bioimpedance Probe (BIP) Needle
Experimental group
Description:
Injeq Bioimpedance Probe (BIP) Needle is a spinal needle that has bioimpedance measurement capability.
Treatment:
Device: Injeq Bioimpedance Probe (BIP) Needle

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems